Poised to challenge need for sleep, "wakefulness enhancer" rouses concerns

JAMA. 2004 Jan 14;291(2):167-70. doi: 10.1001/jama.291.2.167.
No abstract available

Publication types

  • News

MeSH terms

  • Benzhydryl Compounds / pharmacology*
  • Central Nervous System Stimulants / pharmacology*
  • Drug Approval
  • Humans
  • Modafinil
  • Nonprescription Drugs / pharmacology*
  • Sleep / drug effects*
  • United States
  • United States Food and Drug Administration
  • Wakefulness / drug effects*

Substances

  • Benzhydryl Compounds
  • Central Nervous System Stimulants
  • Nonprescription Drugs
  • Modafinil